Physician profile
Charles Willekes
NPI 1801868583
$18,844.77
in general payments reported to CMS, 2019-2025
12 companies · $121 in 2025
The $121 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,155 · 2020: $36.39 · 2021: $153 · 2022: $8,122 · 2023: $8,882 · 2024: $374 · 2025: $121.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,750 · Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,750.00 |
| Food and Beverage | $627.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $9,028.83 | 2021-2025 | Synergy Ablation System |
| Medtronic, INC. | $8,209.67 | 2021-2025 | Valiant Captivia, Avalus, Penditure |
| Medtronic Vascular, INC. | $1,099.77 | 2019 | |
| Ethicon US, LLC | $162.17 | 2019-2025 | Surgicel Nu-Knit, Echelon Flex, Ethicon |
| Abbott Laboratories | $101.89 | 2022-2024 | Epic |
| Baxter Healthcare | $59.81 | 2019-2021 | |
| Abiomed | $54.21 | 2020-2024 | Impella |
| Edwards Lifesciences Corporation | $40.47 | 2021-2023 | Sapien 3 Ultra Resilia |
| Medwest Associates | $27.45 | 2021 | |
| Artivion, INC. | $25.05 | 2019 | |
| Depuy Synthes Sales INC. | $21.88 | 2024 | Matrixrib |
| Getinge USA Sales, LLC | $13.57 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Willekes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.